Journal of Diagnostics Concepts & Practice >

2021 , Vol. 20 >Issue 04: 362 - 367

DOI: https://doi.org/10.16150/j.1671-2870.2021.04.006

Original articles

Evaluation of myocardial fibrosis by cardiac magnetic resonance imaging in patient with myotonic dystrophy type 1

Expand
  • Department of Cardiology, Jing’an District Centre Hospital of Shanghai, Shanghai 200040, China

Received date: 2021-03-20

  Online published: 2022-06-28

Fold

Abstract

Objective: To evaluate myocardial fibrosis by cardiac magnetic resonance (CMR) in the patients with myo-tonic dystrophy type 1 (DM1), and compare the value of CMR and ECG. Methods: A total of 14 patients with genetically conformed DM1 were included, and were performed CMR, electrocardiogram and dynamic electrocardiogram. Myocardial fibrosis was defined as presence of late gadolinium enhancement (LGE) in CMR. According to the results of ECG and/or dynamic ECG, the patients with DM1 were divided into normal ECG and abnormal ECG groups, and the CMR results were compared between two groups. Results: CMR examination showed that the detection rate of myocardial fibrosis in DM1 patients was 35.7% (5 out of 14). Compared with those without myocardial fibrosis, the patients with myocardial fibrosis had higher left ventricular mass index [(47.1±5.4) g/m2 vs. (40.2±3.4) g/m2, P=0.012)], left ventricular end-systolic volume index [(31.5±5.5) mL/m2 vs. (25.8±2.8) mL/m2, P=0.024)], and left atrial volume index [(43.8±7.1) mL/m2 vs. (34.3±7.4) mL/m2, P=0.037), while had lower left ventricular ejection fraction [(52.2±11.1)% vs. (63.9±5.3)%, P=0.019]. There was no correlation between the existence of myocardial fibrosis and the abnormal finding of ECG (44.4% vs. 20.0%, P=0.36) in the patients with DM1, while the other abnormal incidence detected by CMR was higher in abnormal ECG group than in normal ECG group (77.8% vs. 20.0%, P=0.036). Conclusions: Myocardial fibrosis occurs in some patients with DM1. For the patients with DM1, ECG screening fails to predict myocardial fibrosis, while CMR is valuable. Routine cardiac assessments for DM1 patients should include both CMR and ECG.

Key words： Myotonic dystrophy; Myocardial fibrosis; Cardiovascular magnetic resonance

Cite this article

HUANG Shaohua, LIANG Zonghui, TONG Huan, GUAN Xueni, GUO Ying, ZHANG Yan, CAO Bin, SUN Yumin . Evaluation of myocardial fibrosis by cardiac magnetic resonance imaging in patient with myotonic dystrophy type 1[J]. Journal of Diagnostics Concepts & Practice, 2021 , 20(04) : 362 -367 . DOI: 10.16150/j.1671-2870.2021.04.006

References

[1] 王新德. 神经病学:肌肉疾病[M]. 北京: 人民军医出版社, 2007:16-637.
[2] Turner C, Hilton-Jones D. The myotonic dystrophies: dia-gnosis and management[J]. J Neurol Neurosurg Psychiatry, 2010,81(4):358-367.
[3] Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member[J]. Cell, 1992,69(2):385.
[4] Hermans MC, Pinto YM, Merkies IS, et al. Hereditary muscular dystrophies and the heart[J]. Neuromuscul Di-sord, 2010,20(8):479-492.
[5] Chaudhry SP, Frishman WH. Myotonic dystrophies and the heart[J]. Cardiol Rev, 2012,20(1):1-3.
[6] Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, et al. Normal values for cardiovascular magnetic resonance in adults and children[J]. J Cardiovasc Magn Reson, 2015,17(1):29.
[7] Verhaert D, Richards K, Rafael-Fortney JA, et al. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations[J]. Circ Cardiovasc Imaging, 2011,4(1):67-76.
[8] Turkbey EB, Gai N, Lima JA, et al. Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging[J]. Heart Rhythm, 2012,9(10):1691-1697.
[9] Choudhary P, Nandakumar R, Greig H, et al. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy[J]. Heart, 2016,102(18):1472-1478.
[10] Luetkens JA, von Landenberg C, Isaak A, et al. Comprehensive cardiac magnetic resonance for assessment of cardiac involvement in myotonic muscular dystrophy type 1 and 2 without known cardiovascular disease[J]. Circ Cardiovasc Imaging, 2019,12(6):e009100.
[11] Petri H, Ahtarovski KA, Vejlstrup N, et al. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study[J]. J Cardiovasc Magn Reson, 2014,16(1):59.
[12] Cardona A, Arnold WD, Kissel JT, et al. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality[J]. J Cardiovasc Magn Reson, 2019,21(1):26.
[13] Hermans MC, Faber CG, Bekkers SC, et al. Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study[J]. J Cardiovasc Magn Reson, 2012,14(1):48.
[14] de Ambroggi L, Raisaro A, Marchianó V, et al. Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging[J]. Eur Heart J, 1995,16(7):1007-1010.
[15] Nazarian S, Bluemke DA, Wagner KR, et al. QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance[J]. Magn Reson Med, 2010,64(1):107-114.
[16] Chmielewski L, Bietenbeck M, Patrascu A, et al. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myo-tonic dystrophy type 1[J]. Clin Res Cardiol, 2019,108(8):857-867.
[17] Lau JK, Sy RW, Corbett A, et al. Myotonic dystrophy and the heart: a systematic review of evaluation and management[J]. Int J Cardiol, 2015,184:600-608.
[18] Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1[J]. N Engl J Med, 2008,358(25):2688-2697.
[19] Segawa I, Suzuki T, Kato M, et al. Relation between myo-cardial histological changes and ventricular tachycardia in cardiomyopathy: a study by 24-hour ECG-monitoring and endomyocardial biopsy[J]. Heart Vessels Suppl, 1990,5:37-40.
[20] Shiozaki AA, Senra T, Arteaga E, et al. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy[J]. J Cardiovasc Comput Tomogr, 2013,7(3):173-181.
[21] Nguyen HH, Wolfe JT 3rd, Holmes DR Jr, et al. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases[J]. J Am Coll Cardiol, 1988,11(3):662-671.
Options
Outlines

/

〈 〉